/ Wockhardt Gets Tantative Approval For Bendamustine Hydrochloride Injectiom From USFDA ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Thursday, 15 June 2017

The Wockhardt company is pharmaceutical and Biotechnology Company, which include manufacturing and marketing of pharmaceutical and bio pharmaceutical formulation, Vaccines and APIs (Active Pharmaceutical Ingredient).

On Wednesday in the domestic market during evening silver future trading were higher as the investors and speculators they extend their position in the metal and in the US Fed's policy meeting in that meeting they provide further clues on the interest rates of this year.

Central Bank is also expected to raise their interest rates at the meeting. They were planning for the fresh points and the further details on its plan for trimming its balance sheet.

For July 2017 silver future at the MCX the contract is traded at Rs.39037 per kg, and its percentage is up by 0.69%. Opening at Rs.38895 and the previous close was Rs.38771. The intra-day was touched as high of Rs.39074.

The Bandamustine Hydrochloride Injection is used in chemotherapy. On BSE the Wockhardt hit a high of Rs 644.80and a low of Rs 630.70, with 2.9% at Rs 643.25/ share on Thursday morning. On the NSE the traded value is Rs 1,969.62 lakh and the traded volume of shares is 3,07,965, the capitalization of a company is Rs 1,797.41 crore in the free flow of market. Sanofi India, Lupin, Strides Shasun.

or Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔